A Hydrogen Sulphide-releasing Non-steroidal Anti-inflammatory, ATB-346, Significantly Attenuates Human Myometrial Contractions

Overview

Journal Pharmacol Rep

Specialty Pharmacology

Date 2024 Sep 4

PMID 39231921

Authors

Ana Mijuskovic

Susan Wray

Sarah Arrowsmith

Affiliations

Soon will be listed here.

Abstract

Background: Spontaneous preterm birth is the leading cause of perinatal morbidity and mortality. Tocolytics are drugs used to inhibit uterine contractions in cases of imminent preterm birth, however, few are effective in stopping labour once initiated and all have side effects. Combination approaches involving drugs that target multiple signalling pathways that regulate contractions may increase efficacy, reduce dosage and improve tolerability. Both non-steroidal anti-inflammatory drugs (NSAIDs) and hydrogen sulphide (HS)-releasing compounds can reduce myometrial contractions. In a novel approach we evaluated the tocolytic properties of ATB-346-a HS-releasing derivative of the NSAID naproxen, shown clinically to reduce pain and inflammation in arthritis.

Methods: Using organ baths, paired strips of human myometrium were exposed to increasing concentrations of ATB-346, or equimolar concentrations (10µM and 30µM) of the parent drug, naproxen, or the HS-releasing moiety, 4-hydroxy-thiobenzamide (TBZ), alone. The ability of ATB-346 versus the individual components of ATB-346 to decrease ex vivo spontaneous contractions was investigated, and the potency was compared to a known HS donor, NaS.

Results: Acute application of NaS produced a concentration-dependent decrease in force amplitude and force integral (area under the curve) of contraction. ATB-346 produced a more profound decrease in contraction compared to equimolar concentrations of naproxen or TZB alone and was more potent than the equivalent concentration of NaS.

Conclusions: ATB-346 exhibits potent tocolytic properties in human myometrium. These exciting results call for further exploration of ATB-346, with a view to repurposing this or similar drugs as novel therapies for delaying preterm labour.

References

Riddles P, Blakeley R, ZERNER B . Reassessment of Ellman's reagent. Methods Enzymol. 1983; 91:49-60. DOI: 10.1016/s0076-6879(83)91010-8. View

You X, Xu C, Lu J, Zhu X, Gao L, Cui X . Expression of cystathionine β-synthase and cystathionine γ-lyase in human pregnant myometrium and their roles in the control of uterine contractility. PLoS One. 2011; 6(8):e23788. PMC: 3160323. DOI: 10.1371/journal.pone.0023788. View

Arrowsmith S, Keov P, Muttenthaler M, Gruber C . Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development. J Vis Exp. 2018; (131). PMC: 5841565. DOI: 10.3791/56639. View

Hidalgo A, Cantabrana B . Contribution of cAMP to the inhibitory effect of non-steroidal anti-inflammatory drugs in rat uterine smooth muscle. J Auton Pharmacol. 1998; 18(1):31-7. DOI: 10.1046/j.1365-2680.1998.1810031.x. View

Osaghae B, Arrowsmith S, Wray S . Gestational and Hormonal Effects on Magnesium Sulfate's Ability to Inhibit Mouse Uterine Contractility. Reprod Sci. 2020; 27(8):1570-1579. DOI: 10.1007/s43032-020-00185-8. View

Liu W, Xu C, You X, Olson D, Chemtob S, Gao L . Hydrogen Sulfide Delays LPS-Induced Preterm Birth in Mice via Anti-Inflammatory Pathways. PLoS One. 2016; 11(4):e0152838. PMC: 4817991. DOI: 10.1371/journal.pone.0152838. View

Sidhu R, Singh M, Samir G, Carson R . L-cysteine and sodium hydrosulphide inhibit spontaneous contractility in isolated pregnant rat uterine strips in vitro. Pharmacol Toxicol. 2001; 88(4):198-203. DOI: 10.1034/j.1600-0773.2001.d01-104.x. View

Chen Z, Zhang M, Zhao Y, Xu W, Xiang F, Li X . Hydrogen Sulfide Contributes to Uterine Quiescence Through Inhibition of NLRP3 Inflammasome Activation by Suppressing the TLR4/NF-κB Signalling Pathway. J Inflamm Res. 2021; 14:2753-2768. PMC: 8242154. DOI: 10.2147/JIR.S308558. View

Chan W, Berezin I, Daniel E . Effects of inhibition of prostaglandin synthesis on uterine oxytocin receptor concentration and myometrial gap junction density in parturient rats. Biol Reprod. 1988; 39(5):1117-28. DOI: 10.1095/biolreprod39.5.1117. View

10.

Mijuskovic A, Kokic A, Orescanin Dusic Z, Slavic M, Spasic M, Blagojevic D . Chloride channels mediate sodium sulphide-induced relaxation in rat uteri. Br J Pharmacol. 2015; 172(14):3671-86. PMC: 4507168. DOI: 10.1111/bph.13161. View

11.

Sun Q, Chen Z, He P, Li Y, Ding X, Huang Y . Reduced Expression of Hydrogen Sulfide-Generating Enzymes Down-Regulates 15-Hydroxyprostaglandin Dehydrogenase in Chorion during Term and Preterm Labor. Am J Pathol. 2017; 188(1):63-71. DOI: 10.1016/j.ajpath.2017.09.006. View

12.

Jiang B, Tang G, Cao K, Wu L, Wang R . Molecular mechanism for H(2)S-induced activation of K(ATP) channels. Antioxid Redox Signal. 2009; 12(10):1167-78. DOI: 10.1089/ars.2009.2894. View

13.

Wallace J, Nagy P, Feener T, Allain T, Ditroi T, Vaughan D . A proof-of-concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug. Br J Pharmacol. 2019; 177(4):769-777. PMC: 7024706. DOI: 10.1111/bph.14641. View

14.

Wray S, Arrowsmith S, Sharp A . Pharmacological Interventions in Labor and Delivery. Annu Rev Pharmacol Toxicol. 2022; 63:471-489. DOI: 10.1146/annurev-pharmtox-051921-122822. View

15.

Shynlova O, Lee Y, Srikhajon K, Lye S . Physiologic uterine inflammation and labor onset: integration of endocrine and mechanical signals. Reprod Sci. 2012; 20(2):154-67. DOI: 10.1177/1933719112446084. View

16.

Haas D, Caldwell D, Kirkpatrick P, McIntosh J, Welton N . Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ. 2012; 345:e6226. PMC: 4688428. DOI: 10.1136/bmj.e6226. View

17.

Cook J, Zaragoza D, Sung D, Olson D . Expression of myometrial activation and stimulation genes in a mouse model of preterm labor: myometrial activation, stimulation, and preterm labor. Endocrinology. 2000; 141(5):1718-28. DOI: 10.1210/endo.141.5.7474. View

18.

Szabo C . A timeline of hydrogen sulfide (HS) research: From environmental toxin to biological mediator. Biochem Pharmacol. 2017; 149:5-19. PMC: 5862769. DOI: 10.1016/j.bcp.2017.09.010. View

19.

Ellman G . Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82(1):70-7. DOI: 10.1016/0003-9861(59)90090-6. View

20.

Campolo M, Esposito E, Ahmad A, Di Paola R, Paterniti I, Cordaro M . Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice. J Neuroinflammation. 2014; 11:196. PMC: 4265354. DOI: 10.1186/s12974-014-0196-1. View